Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30/06/2025 | 30/06/2024 |
|---|---|---|
| Revenue | 66M | 61M |
| Cost of revenue | 45M | 44M |
| Gross profit | 22M | 17M |
| Research and development | 4M | 5M |
| Selling, general and administrative | 22M | 19M |
| Operating expenses | 27M | 24M |
| Operating income | −5M | −7M |
| Net income | −7M | −8M |
| Earnings per share | −0.40 | −0.50 |
| Earnings per share, diluted | −0.40 | −0.50 |
| Weighted average shares | 17M | 17M |
| Weighted average shares, diluted | 17M | 17M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 2M | 1M | 505,000 | 883,000 | 559,000 | 643,000 |
| Receivables | 4M | 9M |
| Metric | 30/06/2025 | 30/06/2024 |
|---|---|---|
| Operating cash flow | 610,000 | −5M |
| Depreciation and amortisation | 1M | 1M |
| Share-based compensation | 979,000 | 2M |
| Capital expenditure | 653,000 | 853,000 |
| Investing cash flow | −653,000 | −853,000 |
| Financing cash flow | 734,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 7M |
| 11M |
| 10M |
| 8M |
| 10M |
| 10M |
| Inventory | 17M | 16M | 16M | 17M | 16M | 15M | 15M | 17M |
| Current assets | 23M | 28M | 27M | 32M | 27M | 26M | 27M | 28M |
| Property, plant and equipment | 1M | 1M | 2M | 2M | 2M | 2M | 2M | 2M |
| Total assets | 26M | 30M | 30M | 35M | 31M | 29M | 31M | 32M |
| Current liabilities | 21M | 22M | 32M | 40M | 34M | 31M | 31M | 31M |
| Total liabilities | 21M | 23M | 33M | 40M | 35M | 32M | 32M | 32M |
| Equity | 5M | 8M | −3M | −5M | 4M | −3M | −1M | 194,000 |
| Shares outstanding | 21M | 21M | 17M | 17M | 17M | 17M | 17M | 17M |
| Shares issued | 21M | 21M | 17M | 17M | 17M | 17M | 17M | 17M |
| 4M |